NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 292 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,803,220 | -59.8% | 545,091 | +3.3% | 0.00% | -57.1% |
| Q2 2023 | $21,901,708 | +116.2% | 527,752 | +213.3% | 0.01% | +75.0% |
| Q1 2023 | $10,131,364 | +788.7% | 168,463 | +983.9% | 0.00% | +300.0% |
| Q4 2022 | $1,140,079 | +291.8% | 15,543 | +305.5% | 0.00% | – |
| Q3 2022 | $291,000 | -98.5% | 3,833 | -98.6% | 0.00% | -100.0% |
| Q2 2022 | $19,211,000 | +39.8% | 276,418 | +66.7% | 0.01% | +60.0% |
| Q1 2022 | $13,739,000 | -12.9% | 165,829 | -21.1% | 0.01% | 0.0% |
| Q4 2021 | $15,773,000 | -7.3% | 210,075 | +43.4% | 0.01% | -16.7% |
| Q3 2021 | $17,021,000 | -26.9% | 146,516 | +39.5% | 0.01% | -33.3% |
| Q2 2021 | $23,300,000 | +32.6% | 105,041 | -21.0% | 0.01% | 0.0% |
| Q1 2021 | $17,573,000 | -65.3% | 132,943 | -54.6% | 0.01% | -65.4% |
| Q4 2020 | $50,665,000 | +51.9% | 292,797 | -2.3% | 0.03% | +30.0% |
| Q3 2020 | $33,357,000 | +40.7% | 299,688 | -25.1% | 0.02% | +17.6% |
| Q2 2020 | $23,715,000 | +211.4% | 399,905 | +253.6% | 0.02% | +142.9% |
| Q1 2020 | $7,616,000 | -38.5% | 113,100 | -23.0% | 0.01% | -58.8% |
| Q4 2019 | $12,378,000 | -45.7% | 146,897 | -51.8% | 0.02% | -54.1% |
| Q3 2019 | $22,776,000 | +70.6% | 304,583 | +44.3% | 0.04% | +54.2% |
| Q2 2019 | $13,350,000 | +155.3% | 211,142 | +94.5% | 0.02% | +166.7% |
| Q1 2019 | $5,230,000 | +1083.3% | 108,556 | +721.6% | 0.01% | +800.0% |
| Q4 2018 | $442,000 | -3.9% | 13,212 | -41.9% | 0.00% | 0.0% |
| Q4 2017 | $460,000 | -85.2% | 22,759 | -85.4% | 0.00% | -90.0% |
| Q3 2017 | $3,099,000 | +17.8% | 156,100 | +2.7% | 0.01% | +11.1% |
| Q2 2017 | $2,630,000 | – | 152,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |